Offer - Urjas Oil for just ₹ 1 X
Takchlor C Eye Drop, a prescription drug, is manufactured in various forms such as Drops. Secondary and off-label uses of Takchlor C Eye Drop have also been mentioned below.
The optimal dosage of Takchlor C Eye Drop is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Common side effects of Takchlor C Eye Drop include Skin scar, Dryness, Itching or burning. While these are the most often observed Takchlor C Eye Drop side effects, there are can be others also. These have been listed below. These side effects of Takchlor C Eye Drop are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Takchlor C Eye Drop is Unknown for pregnant women and Unknown for women who are breastfeeding. In addition, Takchlor C Eye Drop's effects on the liver, heart and kidney are discussed below in the Takchlor C Eye Drop related warnings section.
Takchlor C Eye Drop is contraindicated in people with pre-existing medical conditions like Kidney Disease, Liver Disease, Infections as it can result in adverse effects. Other conditions have been mentioned below in the Takchlor C Eye Drop contraindications section.
Drug reaction of Takchlor C Eye Drop with other medicines has been reported. See below for a complete list.
In addition to these precautions, you may also note that Takchlor C Eye Drop is not safe while driving, and is is not addictive in nature.
Takchlor C Eye Drop is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Takchlor C Eye Drop safe for pregnant women?
No research has not been done till date on the safety of Takchlor C for pregnant women. So its effects on pregnant women are unknown.
Is the use of Takchlor C Eye Drop safe during breastfeeding?
There is no research available on the side effects of Takchlor C in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Takchlor C Eye Drop on the Kidneys?
Takchlor C rarely affects the kidneys.
What is the effect of Takchlor C Eye Drop on the Liver?
Using Takchlor C does not have any harmful effects on the liver.
What is the effect of Takchlor C Eye Drop on the Heart?
Using Takchlor C does not have any harmful effects on the heart.
Takchlor C Eye Drop should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Takchlor C Eye Drop unless your doctor advises you to do so -
Is this Takchlor C Eye Drop habit forming or addictive?
Takchlor C Eye Drop does not cause addiction.
Interaction between Food and Takchlor C Eye Drop
You can take Takchlor C Eye Drop with food.
Interaction between Alcohol and Takchlor C Eye Drop
It is difficult to say anything about the effect of Takchlor C Eye Drop and alcohol. No research has been done on this yet.
Yes, Takchlor C can cause a headache. It is a known side effect of this drug. If you experience a severe headache after taking this drug, take a mild painkiller, applying balms and complete rest even after this pain does not subside then discuss it with your doctor.
Yes, Takchlor C has been reported to cause diarrhoea and it is the most common side effect of this medicine. Drink plenty of fluids while you are taking this medicine. If you are experiencing severe diarrhoea after taking this drug, consult your doctor immediately without any further delay.
The dosage of Takchlor C may vary from case to case as it depends on the type of infection and severity of the infection. You are recommended to take this drug as per your doctor's instructions. Takchlor C should be taken empty stomach because food may affect absorption of this drug. Precautions must be taken in patients with improper liver or kidney function.
Discontinuing Takchlor C on your own can increase the chances of bacterial resistance and infection relapse. It is recommended that you always consult your doctor if you have decided to discontinue this medicine.
Yes, Takchlor C can cause blurred vision (optic neuritis) but this occurs in a few cases only. It is a known side effect of this drug and it is reversible in nature. Usually, the vision is restored after discontinuation of this drug.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Chloromycetin sodium succinate (chaloramphenicol sodium succinate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 739-742
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 362-366
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 289
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Decadron® (dexamethasone)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hemady™ (dexamethasone)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hexadrol® (dexamethasone sodium phosphate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Polymyxin B
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 759